IEC/TS 62607-6-20 Ed. 1.0 en:2022 PDF

IEC/TS 62607-6-20 Ed. 1.0 en:2022 PDF

Name:
IEC/TS 62607-6-20 Ed. 1.0 en:2022 PDF

Published Date:
10/01/2022

Status:
Active

Description:

Nanomanufacturing - Key control characteristics - Part 6-20: Graphene-based material - Metallic impurity content: Inductively coupled plasma mass spectrometry

Publisher:
International Electrotechnical Commission - Technical Standard

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$70.2
Need Help?

This part of IEC TS 62607 establishes a standardized method to determine the chemical key control characteristic
- metallic impurity content
for powders of graphene-based materials by
- inductively coupled plasma mass spectrometry (ICP-MS).
The metallic impurity content is derived by the signal intensity of measured elements through MS spectrum of ICP-MS.
- The method is applicable for powder of graphene and related materials, including bilayer graphene (2LG), trilayer graphene (3LG), few-layer graphene (FLG), reduced graphene
oxide (rGO) and graphene oxide (GO).
- The typical application area is in the microelectronics industry, e.g. conductive pastes, displays, etc., for manufacturers to guide material design, and for downstream users to select suitable products.


File Size : 1 file , 1.7 MB
ISBN(s) : 9782832257326
Note : This product is unavailable in Canada
Number of Pages : 32
Published : 10/01/2022

History


Related products

IEC/TS 62607-5-3 Ed. 1.0 en:2020
Published Date: 04/14/2020
Nanomanufacturing - Key control characteristics - Part 5-3: Thin-film organic/nano electronic devices ¿¿¿ Measurements of charge carrier concentration
$43.5

Best-Selling Products

AAMI/ISO 10993-1:2003
Published Date: 12/01/2003
Biological Evaluation of Medical Devices Part 1: Evaluation and Testing
$26.4
AAMI/ISO 10993-1:2009 Erratum
Published Date: 06/10/2013
Erratum for Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
Free Download
AAMI/ISO 10993-1:2009/(R)2013
Published Date: 09/03/2009
Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process; Includes Erratum (2013)
AAMI/ISO 10993-1:2018
Published Date: 04/27/2020
Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
$82.5
AAMI/ISO 10993-10:2010/(R)2014
Published Date: 09/04/2010
Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization
$82.5
AAMI/ISO 10993-11:2006/(R)2014
Published Date: 10/19/2006
Biological evaluation of medical devices - Part 11: Tests for systemic toxicity